Phase II study and biomarker analysis of cetuximab in combination with oxaliplatin, 5-fluorouracil, leucovorin as first-line treatment in patients with recurrent or metastatic gastric cancer

被引：0

作者：

Han, S. ^{[1
]}

Park, S. ^{[8
]}

Lee, K. ^{[2
,5
]}

Song, H. ^{[3
]}

Lee, N. ^{[4
]}

Lee, K. ^{[2
,5
]}

Choi, I ^{[6
]}

Lee, M. ^{[7
]}

Kim, M. ^{[1
]}

Oh, D. ^{[1
]}

Im, S. ^{[1
]}

Kim, W. ^{[1
]}

Bang, Y. ^{[1
]}

Kim, T. ^{[1
]}

机构：

[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea

[2] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea

[3] Keimyung Univ, Sch Med, Taegu, South Korea

[4] Soonchunhyang Univ, Coll Med, Seoul, South Korea

[5] Yeungnam Univ, Coll Med, Taegu, South Korea

[6] Seoul Municipal Boramae Hosp, Seoul, South Korea

[7] Inha Univ Hosp, Inchon, South Korea

[8] Natl Canc Ctr, Goyang, South Korea

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：46 / 46

页数：1